Charles River Laboratories reported $263.83M in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agilent A:US $ 466M 3M
Align Technology ALGN:US $ 191.46M 36.25M
Amerisourcebergen ABC:US $ 834.25M 200.1M
Bio Rad Laboratories BIO:US $ 126.62M 48.91M
Bruker BRKR:US $ 107.6M 17.5M
Cardinal Health CAH:US 648M 97M
Catalent CTLT:US $ 315M 39M
Charles River Laboratories CRL:US $ 263.83M 39.76M
CVS Health CVS:US $ 5656M 586M
Danaher DHR:US $ 2757M 20M
Galapagos GLPG:NA € -43.87M 28.24M
Hologic HOLX:US $ 347.9M 352.2M
Illumina ILMN:US $ 275M 145M
IQVIA Holdings Inc IQV:US $ 752M 5M
Laboratory Of America LH:US $ 751.4M 111.8M
Lonza Group LONN:SW 956M 167M
Mckesson MCK:US $ 1222M 326M
Merck MRK:GR € 1791M 161M
Mettler Toledo International MTD:US 299.54M 42.2M
Novartis NOVN:VX SF 4660M 108M
Perkinelmer PKI:US $ 420.38M 11.6M
Pfizer PFE:US $ 12921M 1739M
Quest Diagnostics DGX:US $ 495M 136M
Thermo Fisher Scientific TMO:US $ 2861M 821M
United Therapeutics UTHR:US $ 214.5M 86M
Waters WAT:US $ 233.88M 5.74M
West Pharmaceutical Services WST:US $ 255.6M 37.4M
YTE INCY:US $ 276.8M 132.69M